Abstract
We found that the clinical phenotype associated with BRD4 haploinsufficiency overlapped with that of Cornelia de Lange syndrome (CdLS), which is most often caused by mutation of NIPBL. More typical CdLS was observed with a de novo BRD4 missense variant, which retained the ability to coimmunoprecipitate with NIPBL, but bound poorly to acetylated histones. BRD4 and NIPBL displayed correlated binding at super-enhancers and appeared to co-regulate developmental gene expression.
Your institute does not have access to this article
Relevant articles
Open Access articles citing this article.
-
Cohesin couples transcriptional bursting probabilities of inducible enhancers and promoters
Nature Communications Open Access 27 July 2022
-
3D chromatin architecture and transcription regulation in cancer
Journal of Hematology & Oncology Open Access 04 May 2022
-
The multifaceted roles of cohesin in cancer
Journal of Experimental & Clinical Cancer Research Open Access 14 March 2022
Access options
Subscribe to Nature+
Get immediate online access to the entire Nature family of 50+ journals
$29.99
monthly
Subscribe to Journal
Get full journal access for 1 year
$59.00
only $4.92 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Buy article
Get time limited or full article access on ReadCube.
$32.00
All prices are NET prices.


Change history
03 June 2019
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
References
Hnisz, D. et al. Cell 155, 934–947 (2013).
Rao, S. S. P. et al. Cell 171, 305–320 (2017).
Watrin, E., Kaiser, F. J. & Wendt, K. S. Curr. Opin. Genet. Dev. 37, 59–66 (2016).
Yuan, B. et al. J. Clin. Invest. 125, 636–651 (2015).
Bot, C. et al. J. Cell Sci. 130, 1134–1146 (2017).
Zuin, J. et al. PLoS Genet. 10, e1004153 (2014).
Haarhuis, J. H. I. et al. Cell 169, 693–707 (2017).
Ciosk, R. et al. Mol. Cell 5, 243–254 (2000).
Schwarzer, W. et al. Nature 551, 51–56 (2017).
Deardorff, M. A. et al. Am. J. Hum. Genet. 90, 1014–1027 (2012).
Gil-Rodríguez, M. C. et al. Hum. Mutat. 36, 454–462 (2015).
Musio, A. et al. Nat. Genet. 38, 528–530 (2006).
Deardorff, M. A. et al. Nature 489, 313–317 (2012).
Ansari, M. et al. J. Med. Genet. 51, 659–668 (2014).
Parenti, I. et al. Clin. Genet. 89, 74–81 (2016).
Izumi, K. et al. Nat. Genet. 47, 338–344 (2015).
Deciphering Developmental Disorders Study. Nature 542, 433–438 (2017).
Kline, A. D. et al. Am. J. Med. Genet. A. 143A, 1287–1296 (2007).
Houzelstein, D. et al. Mol. Cell. Biol. 22, 3794–3802 (2002).
Kawauchi, S. et al. PLoS Genet. 5, e1000650 (2009).
Zhang, J. et al. Cancer Discov. 7, 322–337 (2017).
Kanno, T. et al. Nat. Struct. Mol. Biol. 21, 1047–1057 (2014).
Vollmuth, F., Blankenfeldt, W. & Geyer, M. J. Biol. Chem. 284, 36547–36556 (2009).
Gerth-Kahlert, C. et al. Mol. Genet. Genomic Med. 1, 15–31 (2013).
Filippakopoulos, P. et al. Nature 468, 1067–1073 (2010).
Pradeepa, M. M., Sutherland, H. G., Ule, J., Grimes, G. R. & Bickmore, W. A. PLoS Genet. 8, e1002717 (2012).
Turriziani, B. et al. Biology 3, 320–332 (2014).
Cox, J. et al. Mol. Cell. Proteomics 13, 2513–2526 (2014).
Johnson, D. S., Mortazavi, A., Myers, R. M. & Wold, B. Science 316, 1497–1502 (2007).
Pradeepa, M. M. et al. Nat. Genet. 48, 681–686 (2016).
Illingworth, R. S. et al. Genes Dev. 29, 1897–1902 (2015).
Ritchie, M. E. et al. Nucleic Acids Res. 43, e47 (2015).
Langmead, B. & Salzberg, S. L. Nat. Methods 9, 357–359 (2012).
Ramírez, F. et al. Nucleic Acids Res. 44 (W1), W160–W165 (2016).
ENCODE Project Consortium. Nature 489, 57–74 (2012).
Quinlan, A. R. & Hall, I. M. Bioinformatics 26, 841–842 (2010).
Wei, Y. et al. Nucleic Acids Res. 44 (D1), D172–D179 (2016).
Acknowledgements
We thank the CdLS Foundation of the UK and Ireland and particularly the families of the affected children for their time and support for the research. G.O., M.A., H.B., W.A.B., M.M.P. and D.R.F. were funded by the MRC University Unit award to the University of Edinburgh for the MRC Human Genetics Unit. The work of A.v.K. was supported by Carnegie Trust Research Incentive Grant 70382. The DDD study presents independent research commissioned by the Health Innovation Challenge Fund (grant HICF-1009-003), a parallel funding partnership between the Wellcome Trust and the Department of Health, and the Wellcome Trust Sanger Institute (grant WT098051). The views expressed in this publication are those of the authors and not necessarily those of the Wellcome Trust or the Department of Health. The research team acknowledges the support of the National Institute for Health Research through the Comprehensive Clinical Research Network.
Author information
Authors and Affiliations
Consortia
Contributions
W.A.B., M.M.P. and D.R.F. conceived the study. D.R.F., W.A.B. and M.M.P. wrote the manuscript. All of the authors read and commented on the manuscript. G.O., M.A., H.B., N.C., M.M.P. and the DDD study generated the molecular biology and animal model data. A.v.K. generated and analyzed the mass spectrometry data. F.J.S., E.W., A.R. and S.M.P. provided expert clinical interpretation and details of the phenotype for each affected individual. A.B. performed the meta-analysis of the reported deletion cases. J.R. provided expert technical advice and cell reagents. G.R.G. performed the genomic and transcriptomic informatic analysis.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Additional information
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Supplementary Text and Figures
Supplementary Figures 1–20, Supplementary Tables 1–3 and Supplementary Note
Supplementary Table 4
BRD4 immunoprecipitation data
Rights and permissions
About this article
Cite this article
Olley, G., Ansari, M., Bengani, H. et al. BRD4 interacts with NIPBL and BRD4 is mutated in a Cornelia de Lange–like syndrome. Nat Genet 50, 329–332 (2018). https://doi.org/10.1038/s41588-018-0042-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41588-018-0042-y
Further reading
-
3D chromatin architecture and transcription regulation in cancer
Journal of Hematology & Oncology (2022)
-
The multifaceted roles of cohesin in cancer
Journal of Experimental & Clinical Cancer Research (2022)
-
Cohesin couples transcriptional bursting probabilities of inducible enhancers and promoters
Nature Communications (2022)
-
Loss of TAF8 causes TFIID dysfunction and p53-mediated apoptotic neuronal cell death
Cell Death & Differentiation (2022)
-
Dicer promotes genome stability via the bromodomain transcriptional co-activator BRD4
Nature Communications (2022)